China Life Insurance Company Limited (601628.SS)
Beijing, CN
Operating across the People's Republic of China, China Life Insurance Company Limited, along with its various subsidiaries, serves as a leading insurance provider. The company organizes its operations into four main divisions: Life Insurance, Health Insurance, Accident Insurance, and other associated business activities. Its comprehensive range of offerings includes critical illness coverage, various annuity products, specialized policies catering to children, women, and pension needs, in addition to general security, medical, and accident protection plans. The company was founded in 1949 and has its main base of operations in Beijing. China Life Insurance Company Limited is an integral part of the broader China Life Insurance (Group) Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.13% | -3.46% | -4.02% | -24.01% | -19.57% | -20.86% | -5.11% | -15.77% | +10.73% | +73.63% | -8.74% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 5 | 0 |
| Hold | 8 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Insurance - Life: +10.6%+18.1% ★ Q1'26: +26.9% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+44.2% ★ Q1'26: -32.4% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+28.3% ★ Q1'26: +168.2% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+30.7% ★ Q1'26: +15.3% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+16.7% ★ Q1'26: +11.1% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%-0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.93× Q1'26: 3.35× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 10 EPS Ana. |
Dec 2027 4 Rev. Ana. 6 EPS Ana. |
Dec 2028 2 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
402.55B
est: 372.24B (+8.1%)
|
472.61B
est: 429.16B (+10.1%)
|
555.73B
est: 504.13B (+10.2%)
|
518.79B
est: 535.19B (-3.1%)
|
689.17B
est: 577.35B (+19.4%)
|
778.86B
est: 614.42B (+26.8%)
|
794.69B
est: 644.27B (+23.3%)
|
822.31B
est: 609.46B (+34.9%)
|
396.47B
est: 634.59B (-37.5%)
|
512.20B
est: 604.44B (-15.3%)
|
605.11B
est: 647.19B (-6.5%)
|
619.22B
551.05B – 687.38B
-4.3% YoY
|
665.59B
529.93B – 829.45B
+7.5% YoY
|
715.88B
603.91B – 842.85B
+7.6% YoY
|
| EBITDA |
—
est: 31.24B (-100.0%)
|
—
est: 36.02B (-100.0%)
|
—
est: 42.31B (-100.0%)
|
—
est: 44.92B (-100.0%)
|
—
est: 48.46B (-100.0%)
|
—
est: 51.57B (-100.0%)
|
—
est: 54.08B (-100.0%)
|
33.84B
est: 51.16B (-33.9%)
|
57.00B
est: 53.27B (+7.0%)
|
120.24B
est: 88.83B (+35.4%)
|
190.68B
est: 95.11B (+100.5%)
|
91.00B
80.98B – 101.02B
-4.3% YoY
|
97.81B
77.88B – 121.90B
+7.5% YoY
|
105.21B
88.75B – 123.86B
+7.6% YoY
|
| EBIT |
—
est: 29.13B (-100.0%)
|
—
est: 33.58B (-100.0%)
|
—
est: 39.45B (-100.0%)
|
—
est: 41.88B (-100.0%)
|
—
est: 45.17B (-100.0%)
|
—
est: 48.07B (-100.0%)
|
—
est: 50.41B (-100.0%)
|
28.91B
est: 47.69B (-39.4%)
|
51.99B
est: 49.65B (+4.7%)
|
115.21B
est: 84.41B (+36.5%)
|
185.79B
est: 90.38B (+105.6%)
|
86.47B
76.95B – 95.99B
-4.3% YoY
|
92.95B
74.00B – 115.83B
+7.5% YoY
|
99.97B
84.34B – 117.70B
+7.6% YoY
|
| Net Income |
34.70B
est: 39.09B (-11.2%)
|
19.13B
est: 19.58B (-2.3%)
|
32.25B
est: 32.21B (+0.1%)
|
11.40B
est: 17.44B (-34.7%)
|
58.29B
est: 58.86B (-1.0%)
|
50.26B
est: 51.97B (-3.3%)
|
50.77B
est: 55.70B (-8.9%)
|
32.08B
est: 37.38B (-14.2%)
|
51.18B
est: 28.66B (+78.6%)
|
106.94B
est: 111.51B (-4.1%)
|
154.08B
est: 167.66B (-8.1%)
|
132.68B
105.70B – 163.27B
-20.9% YoY
|
144.24B
114.91B – 177.50B
+8.7% YoY
|
159.09B
126.74B – 195.77B
+10.3% YoY
|
| SGA |
27.96B
est: 11.87B (+135.5%)
|
32.63B
est: 13.69B (+138.4%)
|
36.74B
est: 16.08B (+128.5%)
|
38.30B
est: 17.07B (+124.4%)
|
41.17B
est: 18.41B (+123.6%)
|
38.70B
est: 19.59B (+97.5%)
|
41.89B
est: 20.55B (+103.9%)
|
24.21B
est: 19.44B (+24.6%)
|
25.65B
est: 20.24B (+26.8%)
|
-19.00B
est: 9.37B (-302.8%)
|
-19.53B
est: 10.03B (-294.7%)
|
9.60B
8.54B – 10.65B
-4.3% YoY
|
10.31B
8.21B – 12.85B
+7.5% YoY
|
11.09B
9.36B – 13.06B
+7.6% YoY
|
| EPS |
1.22
est: 1.38 (-11.7%)
|
0.66
est: 0.69 (-4.6%)
|
1.13
est: 1.14 (-0.7%)
|
0.39
est: 0.62 (-36.7%)
|
2.05
est: 2.08 (-1.5%)
|
1.77
est: 1.84 (-3.7%)
|
1.80
est: 1.97 (-8.6%)
|
1.14
est: 1.32 (-14.1%)
|
1.81
est: 1.01 (+78.6%)
|
3.78
est: 3.95 (-4.2%)
|
5.45
est: 5.93 (-8.1%)
|
4.69
3.74 – 5.78
-20.9% YoY
|
5.10
4.07 – 6.28
+8.7% YoY
|
5.63
4.48 – 6.93
+10.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | JPMorgan ETFs (Ireland) ICAV - China A Research Enhanced Index Equity Active UCITS ETF JREC.L | 0.44% | 100.9K | 0.40% |
| 2 | HSBC MSCI China A UCITS ETF HMCT.L | 0.28% | 373.7K | 0.30% |
| 3 | Xtrackers Harvest CSI 300 China A-Shares ETF ASHR | 0.25% | 3.32M | 0.65% |
| 4 | Samsung KODEX China CSI300 ETF 283580.KS | 0.23% | 465.9K | 0.12% |
| 5 | Xtrackers Harvest CSI300 UCITS ETF 1D ASHR.L | 0.23% | 715.2K | 0.65% |
| 6 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.20% | 32.0K | 0.65% |
| 7 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.17% | 237.7K | 0.35% |
| 8 | iShares MSCI China A UCITS ETF CNYE.MI | 0.17% | 167.0K | 0.45% |
| 9 | iShares MSCI China A UCITS ETF CNYA.L | 0.17% | 5.06M | 0.40% |
| 10 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.15% | 207.6K | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhong Zhan | Vice President, Marketing Director & GM of Individual Insurance Division | 2M | male |
| Hui Liu | Vice President, Chief Investment Officer, Executive Director, Board Secretary | 2M | female |
| Ruan Qi | Vice President, Chief Cybersecurity Officer, Chief Risk Officer & Executive Director | 2M | male |
| Chongmiao Xu | Chief Compliance Officer & Head of Compliance | 1M | male |
| Jin Hou | Chief Actuary | 1M | female |
| Xinyu Zhang | Assistant to the President | 440.2K | — |
| Yonghong Lan | Assistant to the President | 440.2K | — |
| Ying Yuan | Accounting Supervisor & CFO | — | female |
| Xiliang Cai | Executive Chairman of the Board | — | male |
| Mingguang Li | President & Executive Director | — | male |
| Qun Huo | Assistant President | — | — |
| Jingwei Hu | Head of Budget Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 601628.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
